Scott M Coiante - Net Worth and Insider Trading
Scott M Coiante Net Worth
The estimated net worth of Scott M Coiante is at least $424 dollars as of 2024-12-27. Scott M Coiante is the SVP, CFO of Aprea Therapeutics Inc and owns about 125 shares of Aprea Therapeutics Inc (APRE) stock worth over $421. Scott M Coiante is also the VP and CFO of Agile Therapeutics Inc and owns about 2 shares of Agile Therapeutics Inc (AGRX) stock worth over $3. Details can be seen in Scott M Coiante's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott M Coiante has not made any transactions after 2019-10-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott M Coiante
Scott M Coiante Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott M Coiante owns 2 companies in total, including Aprea Therapeutics Inc (APRE) , and Agile Therapeutics Inc (AGRX) .
Click here to see the complete history of Scott M Coiante’s form 4 insider trades.
Insider Ownership Summary of Scott M Coiante
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2020-03-24 | SVP & Chief Financial Officer |
| AGRX | Agile Therapeutics Inc | 2023-08-16 | Chief Financial Officer |
Scott M Coiante Latest Holdings Summary
Scott M Coiante currently owns a total of 2 stocks. Among these stocks, Scott M Coiante owns 125 shares of Aprea Therapeutics Inc (APRE) as of October 7, 2019, with a value of $421 and a weighting of 99.29%. Scott M Coiante also owns 2 shares of Agile Therapeutics Inc (AGRX) as of May 22, 2014, with a value of $3 and a weighting of 0.71%.
Latest Holdings of Scott M Coiante
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2019-10-07 | 125 | 3.37 | 421 |
| AGRX | Agile Therapeutics Inc | 2014-05-22 | 2 | 1.51 | 3 |
Holding Weightings of Scott M Coiante
Scott M Coiante Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott M Coiante has made a total of 0 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 125 shares on October 7, 2019, which cost Scott M Coiante around $37,500.
According to the SEC Form 4 filings, Scott M Coiante has made a total of 0 transactions in Agile Therapeutics Inc (AGRX) over the past 5 years. The most-recent trade in Agile Therapeutics Inc is the sale of 0 shares on May 22, 2014, which brought Scott M Coiante around $0.
Insider Trading History of Scott M Coiante
- 1
Scott M Coiante Trading Performance
GuruFocus tracks the stock performance after each of Scott M Coiante's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott M Coiante is 115.11%. GuruFocus also compares Scott M Coiante's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott M Coiante within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott M Coiante's insider trading performs compared to the benchmark.
Performance of Scott M Coiante
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.41 | | | | | |
| Relative Return to S&P 500(%) | 14.43 | | | | | |
Scott M Coiante Ownership Network
Scott M Coiante Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Scott M Coiante is the SVP & Chief Financial Officer of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Scott M Coiante made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 3,900 shares made by Oren Gilad , a net purchase of 23,728 shares made by Marc Duey , and a net purchase of 1,510 shares made by John P. Hamill .
In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 59,320 shares were bought by its insiders, resulting in a net purchase of 52,858 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Scott M Coiante Mailing Address
Above is the net worth, insider trading, and ownership report for Scott M Coiante. You might contact Scott M Coiante via mailing address: 101 Poor Farm Road 3rd Floor, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
